BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4792112)

  • 1. Studies on lankacidin-group (T-2636) antibiotics. VII. Structure-activity relationships of lankacidin-group antibiotics.
    Harada S; Yamazaki T; Hatano K; Tsuchiya K; Kishi T
    J Antibiot (Tokyo); 1973 Nov; 26(11):647-57. PubMed ID: 4792112
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative structure--activity relationships in leucomycin and lincomycin antibiotics.
    Martin YC; Lynn KR
    J Med Chem; 1971 Dec; 14(12):1162-6. PubMed ID: 5000561
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on lankacidin-group (T-2636) antibiotics. V. Chemical structures of lankacidin-group antibiotics. 1.
    Harada S; Kishi T
    Chem Pharm Bull (Tokyo); 1974 Jan; 22(1):99-108. PubMed ID: 4833376
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships.
    Oostu K; Matsumoto T; Harada S; Kishi T
    Cancer Chemother Rep; 1975; 59(5):919-28. PubMed ID: 1148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on lankacidin-group (T-2636) antibiotics. VI. Chemical structures of lankacidin-group antibiotics. II.
    Harada S
    Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2201-10. PubMed ID: 1212749
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of structures and microbiological activities of the 16-membered macrolides.
    Omura S; Tishler M
    J Med Chem; 1972 Oct; 15(10):1011-5. PubMed ID: 4627057
    [No Abstract]   [Full Text] [Related]  

  • 8. Side chain modifications in lankacidin group antibiotics.
    McFarland JW; Pirie DK; Retsema JA; English AR
    Antimicrob Agents Chemother; 1984 Feb; 25(2):226-33. PubMed ID: 6370129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antimicrobial activities of 9(S)-N,N-dimethyl-amino-9-deoxo-10, 11,12,13-tetrahydroniddamycin.
    Maring CJ; Freiberg LA; Lartey PA; Grampovnik DJ; Edwards CM; Hardy DJ; Swanson R; Fernandes PB
    J Antibiot (Tokyo); 1991 Apr; 44(4):448-50. PubMed ID: 2032953
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production of a new antibiotic, chalcidin, from Micromonospora chalcea culture].
    Gauze GF; Brazhnikova MG; Shorin VA; Maksimova TS; Ol'khovatova OL; Kudinova MK; Vishniakova IA; Pevzner NS; Shapovalova SP
    Antibiotiki; 1970 Jun; 15(6):483-6. PubMed ID: 4394064
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bacteriological studies on staphylomycin].
    Nakazawa S; Yokota Y; Ueda Y; Shiraishi K; Akiba A
    Jpn J Antibiot; 1968 Feb; 21(1):15-8. PubMed ID: 4875184
    [No Abstract]   [Full Text] [Related]  

  • 12. A54145 a new lipopeptide antibiotic complex: microbiological evaluation.
    Counter FT; Allen NE; Fukuda DS; Hobbs JN; Ott J; Ensminger PW; Mynderse JS; Preston DA; Wu CY
    J Antibiot (Tokyo); 1990 Jun; 43(6):616-22. PubMed ID: 2380110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maridomycin, a new macrolide antibiotic: in vivo antibacterial activity of 9-propionylmaridomycin.
    Kondo M; Ishifuji K; Tsuchiya K; Goto S; Kuwahara S
    Antimicrob Agents Chemother; 1973 Aug; 4(2):156-9. PubMed ID: 4790936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry and biology of the polyene macrolide antibiotics.
    Hamilton-Miller JM
    Bacteriol Rev; 1973 Sep; 37(3):166-96. PubMed ID: 4202146
    [No Abstract]   [Full Text] [Related]  

  • 15. Topochemical approach in studies of the structure-activity relation: enantio-enniatin B.
    Shenyakin MM; Ovchinnikov YA; Ivanov VT; Evstratov AV
    Nature; 1967 Jan; 213(5074):412-3. PubMed ID: 4961750
    [No Abstract]   [Full Text] [Related]  

  • 16. Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens.
    Or YS; Clark RF; Wang S; Chu DT; Nilius AM; Flamm RK; Mitten M; Ewing P; Alder J; Ma Z
    J Med Chem; 2000 Mar; 43(6):1045-9. PubMed ID: 10737737
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on lankacidin-group (T-2636) antibiotics. X. Microbial conversion of lankacidin-group antibiotics.
    Nakahama K; Harada S; Igarasi S
    J Antibiot (Tokyo); 1975 May; 28(5):390-4. PubMed ID: 240790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
    Shorin VA; Shapovalova SP
    Antibiotiki; 1974 Jan; 19(1):3-6. PubMed ID: 4156904
    [No Abstract]   [Full Text] [Related]  

  • 19. [Josamycin propionate. 1. Physicochemical and biological properties].
    Osono T; Yano K; Murakami K; Miyamoto F; Murakami K
    Jpn J Antibiot; 1973 Apr; 26(2):115-21. PubMed ID: 4542537
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological studies on bottromycin A and its hydrazide.
    Tanaka N; Nishimura T; Nakamura S; Umezawa H
    J Antibiot (Tokyo); 1966 Jul; 19(4):149-54. PubMed ID: 6013173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.